TGFB1 and breast carcinoma: To this end, significant survival advantage was conferred on two breast cancer cell lines, MCF7 and MDA-MB-468, by treating them with the cytokine TGF-β and chemotherapeutic drugs to induce stochastic alternations and clonal evolution.